Evolving antimicrobial chemotherapy for Staphylococcus aureus infections: Our backs to the wall


    loading  Checking for direct PDF access through Ovid

Abstract

Staphylococcus aureus is responsible for many nosocomial and community-acquired infections. Its evolving resistance to traditional antimicrobial chemotherapy and emerging prevalence outside of the healthcare environment are serious concerns. This review of the changing epidemiology of methicillin-resistant S. aureus, the emergence of vancomycin (glycopeptide)-resistant isolates, and the mechanisms of resistance to β-lactams and glycopeptides provides an update for clinicians regarding effective strategies for treatment.

    loading  Loading Related Articles